Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue

被引:130
作者
Galanski, Markus [1 ]
Keppler, Bernhard K. [1 ]
机构
[1] Univ Vienna, Inst Inorgan Chem, A-1090 Vienna, Austria
关键词
Platinum complexes; anticancer activity; mechanism of action; structure-activity relationships; synthesis; medicinal chemistry; accumulation; activation;
D O I
10.2174/187152007779314017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cisplatin, carboplatin and oxaliplatin are anticancer drugs, which are efficiently used in the clinics all over the world. Besides a remarkable therapeutic efficacy in a series of solid tumors and outstanding activity of cisplatin against testicular germ-cell cancer, the platinum-based therapy is in part accompanied by a set of severe toxic side-effects. The design of platinum complexes being equipped with an exclusive selectivity for the tumoral tissue and exhibiting a lack of systemic toxicity ('magic bullets') is the great hope in the fight against cancer and also a motor within the expanding field of bioinorganic chemistry. In this review article, two promising strategies, namely accumulation and activation of tumor inhibiting platinum complexes specifically at the tumor site is presented, demonstrating a stepwise approach towards the 'magic bullet' concept propagated by Paul Ehrlich.
引用
收藏
页码:55 / 73
页数:19
相关论文
共 160 条
[1]   Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer [J].
Ahn, JH ;
Kang, YK ;
Kim, TW ;
Bahng, H ;
Chang, HM ;
Kang, WC ;
Kim, WK ;
Lee, JS ;
Park, JS .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) :104-110
[2]   Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy [J].
Amorino, GP ;
Mohr, PJ ;
Hercules, SK ;
Pyo, H ;
Choy, H .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (05) :423-426
[3]   Radiopotentiation by the oral platinum agent, JM216: Role of repair inhibition [J].
Amorino, GP ;
Freeman, ML ;
Carbone, DP ;
Lebwohl, DE ;
Choy, H .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (02) :399-405
[4]  
Amtmann E, 2001, CANCER CHEMOTH PHARM, V47, P461
[5]   Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance [J].
Ang, WH ;
Khalaila, I ;
Allardyce, CS ;
Juillerat-Jeanneret, L ;
Dyson, PJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (05) :1382-1383
[6]   Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies [J].
Aronov, O ;
Horowitz, AT ;
Gabizon, A ;
Gibson, D .
BIOCONJUGATE CHEMISTRY, 2003, 14 (03) :563-574
[7]   Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues [J].
Aronov, O ;
Horowitz, AT ;
Gabizon, A ;
Fuertes, MA ;
Pérez, JM ;
Gibson, D .
BIOCONJUGATE CHEMISTRY, 2004, 15 (04) :814-823
[8]   Control of tumour vascular permeability [J].
Baban, DF ;
Seymour, LW .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (01) :109-119
[9]   Studies on the oral anticancer drug JM-216: Synthesis and characterization of isomers and related complexes [J].
Barnard, CFJ ;
Vollano, JF ;
Chaloner, PA ;
Dewa, SZ .
INORGANIC CHEMISTRY, 1996, 35 (11) :3280-3284
[10]   Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes [J].
Barnes, KR ;
Kutikov, A ;
Lippard, SJ .
CHEMISTRY & BIOLOGY, 2004, 11 (04) :557-564